EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The senescence–immune axis as a target for combining immunotherapy and senotherapy

Fernanda Saez-Calazans, Lucas Kich Grun, Lucas Emanuel Stein, Florencia Barbé-Tuana, Eduardo Cremonese Filippi-Chiela

Ageing Research Reviews · 2026-11 · 122 · 103309

DOI: 10.1016/j.arr.2026.103309 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-11. Verfasst von Fernanda Saez-Calazans und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre (HCPA), Porto Aleg…. Hauptthemen laut MEDLINE: Immunotherapy, Cellular Senescence, Aging, Senotherapeutics. Die Arbeit nennt 312 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Clinics Hospital of Porto Alegre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence and immune dysfunction intersect as central biological processes shaping disease progression and therapeutic responses across ageing-related pathologies. Rather than acting independently, senescent cells (SnCs) and immune cells engage in a dynamic and bidirectional crosstalk that influences immune surveillance, inflammatory signaling, and tissue remodeling. This review focuses on the molecular and cellular mechanisms through which SnCs modulate immune composition and function, emphasizing immune checkpoint ligands, stress-associated surface molecules, and senescence-associated transcriptional programs governing senescence-associated secretory phenotype (SASP) expression. We further examine how immune-targeted therapies can, in turn, remodel senescent niches by promoting immune-mediated clearance or altering senescence-associated phenotypes. Integrating evidence from cancer to metabolic and chronic inflammatory diseases, we discuss how senotherapies reshape immune landscapes and how immunotherapies impact senescent cell burden and function. Building on these mechanistic insights, we propose that the senescence-immune axis constitutes a tractable therapeutic vulnerability that can be exploited through rational combination strategies. Finally, we outline five conceptual frameworks and biomarker-guided trial archetypes for integrating senotherapies and immunotherapies in a bidirectional crosstalk, aiming to enhance therapeutic efficacy while mitigating ageing- and treatment-associated toxicities. By reframing senescence and immunity as interconnected therapeutic targets, this review provides a mechanistic foundation for next-generation combinatorial interventions across ageing-associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCellular SenescenceAgingSenotherapeuticsHumansAnimalsSenescence-Associated Secretory PhenotypeNeoplasms

Stichwörter der Autor:innen

CancerImmune responseImmunotherapyInflammationSenescenceSenotherapy

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil; Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
  • Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
  • Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
  • Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil; Centro de Biotecnologia; Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil; Departamento de Ciências Morfológicas, UFRGS,…

Förderung

  • National Council for Scientific and Technological Development
  • Clinics Hospital of Porto Alegre

Zitieren

APA

Saez-Calazans, F., Grun, L. K., Stein, L. E., Barbé-Tuana, F., & Filippi-Chiela, E. C. (2026). The senescence–immune axis as a target for combining immunotherapy and senotherapy. Ageing Research Reviews, 122, 103309. https://doi.org/10.1016/j.arr.2026.103309

Vancouver

Saez-Calazans F, Grun LK, Stein LE, Barbé-Tuana F, Filippi-Chiela EC. The senescence–immune axis as a target for combining immunotherapy and senotherapy. Ageing Research Reviews. 2026;122:103309. doi:10.1016/j.arr.2026.103309

BibTeX
@article{SaezCalazans2026,
  author = {Saez-Calazans, Fernanda and Grun, Lucas Kich and Stein, Lucas Emanuel and Barbé-Tuana, Florencia and Filippi-Chiela, Eduardo Cremonese},
  title = {The senescence–immune axis as a target for combining immunotherapy and senotherapy},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {122},
  pages = {103309},
  doi = {10.1016/j.arr.2026.103309}
}
Kostenlos starten →